Cuorips Inc. (TYO:4894)

Japan flag Japan · Delayed Price · Currency is JPY
7,580.00
+820.00 (12.13%)
Aug 29, 2025, 3:30 PM JST
12.13%
Market Cap62.21B
Revenue (ttm)260.00M
Net Income (ttm)-652.00M
Shares Out8.21M
EPS (ttm)-81.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,066,600
Average Volume273,335
Open7,000.00
Previous Close6,760.00
Day's Range6,930.00 - 7,740.00
52-Week Range4,145.00 - 10,050.00
Beta0.67
RSI63.16
Earnings DateAug 13, 2025

About Cuorips

Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 56
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4894
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.